Advertisement

Comparative Clinical Pathology

, Volume 24, Issue 6, pp 1417–1434 | Cite as

Effect of Cannabis sativa extract on gastric acid secretion, oxidative stress and gastric mucosal integrity in rats

  • Omar M. E. Abdel-SalamEmail author
  • Rania Abdallah Ali Salama
  • Ezz-Eddin El-Denshary
  • Amany Ameen Sleem
  • Marawa El-Sayed El-Shamarka
  • Nabila Salah Hassan
Original Article

Abstract

Studies were conducted in pylorus-ligated rats to investigate the effect of Cannabis sativa extract on gastric acid secretion, experimental gastric ulcer and on oxidative stress and inflammatory markers in the gastric mucosa. C. sativa (5, 10 and 20 mg/kg, expressed as Δ9-tetrahydrocannabinol) was administered subcutaneously daily for 4 weeks prior to pylorus ligation and different treatments. Under basal conditions, pretreatment with cannabis extract at doses of 5 and 10 mg/kg increased gastric acid secretion and induced minimally visible gastric mucosal lesions in the 4 h pylorus-ligated rat. Malondialdehyde and nitric acid concentration increased, while reduced glutathione decreased by cannabis at doses of 5 and 10 mg/kg in gastric mucosa. TNF-α increased by cannabis extract at doses of 5 and 10 mg/kg but decreased following the high dose of 20 mg/kg. On the other hand, the gastric acid secretory responses stimulated by pentagastrin or carbachol (but not histamine) were inhibited in rats pretreated with cannabis extract. Under these conditions, cannabis decreased pepsin content after pentagastrin and carbachol but not histamine stimulation. Cannabis also decreased lipid peroxidation and nitric oxide content, and increased both reduced glutathione and catalase activity in mucosa. Moreover, cannabis decreased mucosal inflammation (level of TNF-α) and the development of gastric mucosal lesions. Cannabis administered for 1 month prior to pylorus-ligation and either acidified aspirin or ethanol (96 %) decreased the development of gastric mucosal damage in a dose-dependent manner, along with reduction in gastric acid output, gastric mucosal oxidative stress and inflammation (TNF-α). Sections of gastric mucosa stained with periodic acid Schiff showed increased mucus secretion by cannabis in basal conditions and after treatment with aspirin or ethanol. Results indicate that: (1) the effect of cannabis differs in basal conditions and after exposure of the gastric mucosa to high acid concentrations or other chemical noxious agents; (2) cannabis administered systemically exerts gastric mucosal protective effects against mucosal damage evoked by stimulation of gastric acid secretion, acidified aspirin or ethanol. These effects of cannabis are likely to involve inhibition of gastric acid and pepsin secretion, increased mucus, decreased oxidative stress and inflammation in gastric mucosa.

Keywords

Cannabis sativa Gastric ulcer Gastric acid Oxidative stress Rat 

References

  1. Adami M, Frati P, Bertini S, Kulkarni-Narla A, Brown DR, de Caro G, Coruzzi G, Soldani G (2002) Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach. Br J Pharmacol 135:1598–1606PubMedCentralCrossRefPubMedGoogle Scholar
  2. Adami M, Zamfirova R, Sotirov E, Tashev R, Dobrinova Y, Todorov S, Coruzzi G (2004) Gastric antisecretory effects of synthetic cannabinoids after central or peripheral administration in the rat. Brain Res Bull 64:357–361CrossRefPubMedGoogle Scholar
  3. Aebi H (1984) Catalase in vitro. Methods Enzymol 108:121–126CrossRefGoogle Scholar
  4. Agus SS (2005) Gastroprotective effect of curcumine on ethanol-induced gastric mucosal lesions in rats. Folia Med Indones 41:85–89Google Scholar
  5. Aihara T, Nakamura E, Amagase K, Tomita K, Fujishita T, Furutani K, Okabe S (2003) Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future. Pharmacol Ther 98:109–127CrossRefPubMedGoogle Scholar
  6. Aivado M, Spentzos D, Germing U, Alterovitz G, Meng XY, Grall F, Giagounidis AAN, Klement G, Steidl U, Otu HH, Czibere A et al (2007) Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Science 104:1307–1312Google Scholar
  7. Allen A, Flemström G (2005) Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 288:1–19CrossRefGoogle Scholar
  8. Allen A, Pearson JP, Blackburn A, Coan RM, Hutton DA, Mall AS (1988) Pepsins and the mucus barrier in peptic ulcer disease. Scand J Gastroenterol 23:50–57CrossRefGoogle Scholar
  9. Allen A, Flemstrom G, Garner A, Kivilaakso E (1993) Gastroduodenal mucosal protection. Physiol Rev 73:823–857PubMedGoogle Scholar
  10. Ashton CH (2001) Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 178:101–106CrossRefPubMedGoogle Scholar
  11. Banerjee R (1990) Non-steroidal anti-inflammatory drugs inhibit gastric peroxides activity. Biochim Biophys Acta 1034:275–280CrossRefPubMedGoogle Scholar
  12. Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888PubMedGoogle Scholar
  13. Brenneisen R (2006) Chemistry and analysis of phytocannabinoids and other cannabis constituents. In: ElSohly MA (ed) Forensic science and medicine: marijuana and the cannabinoids. Humana, Totowa, pp 17–49Google Scholar
  14. Calatayud S, Barrachina D, Espluges JV (2001) Nitric oxide:relation to integrity, injury, and healing of the gastric mucosa. Microsc Res Tech 53:325–335CrossRefPubMedGoogle Scholar
  15. Coruzzi G, Adami M, Coppelli G, Frati P, Soldani G (1999) Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat. Naunyn Schmiedebergs Arch Pharmacol 360:715–8Google Scholar
  16. Coruzzi G, Adami M, Guaita E, Menozzi A, Bertini S, Giovannini E, Soldani G (2006) Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data. Dig Dis Sci 51:310–317CrossRefPubMedGoogle Scholar
  17. Cosku O, Kanter M, Armutcu F, Cetin K, Katbalmaz B, Yazgan O (2004) Protective effect of quercetin and flavonoid antioxidant, in absolute induced gastric ulcer. Eur J Gen Med 1:37–42Google Scholar
  18. Davenport HW (1964) Gastric mucosal injury by fatty and acetylsalicylic acids. Gastroenterology 46:245–253PubMedGoogle Scholar
  19. Dembiński A, Warzecha Z, Ceranowicz P, Dembiński M, Cieszkowski J, Pawlik W, Konturek SJ, Tomaszewska R, Hładki W, Konturek PC (2006) Cannabinoids in acute gastric damage and pancreatitis. J Physiol Pharmacol 57:137–154PubMedGoogle Scholar
  20. Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605–613PubMedGoogle Scholar
  21. Ehrlich K, Sicking C, Respondek M, Peskar BM (2004) Interaction of cyclooxygenase isoenzymes, nitric oxide, and afferent neurons in gastric mucosal defense in rats. J Pharmacol Exp Ther 308:277–283CrossRefPubMedGoogle Scholar
  22. Elsohly MA, Slade D (2005) Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 78:539–548CrossRefPubMedGoogle Scholar
  23. Farinati F, Della Libera G, Cardin R, Molari A, Plebani M, Rugge M, Di Mario F, Naccarato R (1996) Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection. J Clin Gastroenterol 22:275–281CrossRefPubMedGoogle Scholar
  24. Gabriel GC, Mauricio HP, Eliana SV, Zurita E, Palacios M, Gutiérrez O (2006) Study of the gastric acid anti-secretory activity of Cannabis sativa in an animal model. Colomb Méd 37:4Google Scholar
  25. Germanò MP, D'Angelo V, Mondello MR, Pergolizzi S, Capasso F, Capasso R, Izzo AA, Mascolo N, De Pasquale R (2001) Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats. Naunyn Schmiedeberg’s Arch Pharmacol 363:241–244CrossRefGoogle Scholar
  26. Glavin GB, Szabo S (1993) Effects of the cachelators EGTA and EDTA on ethanol- or stress-induced gastric mucosal lesions and gastric secretion. Eur J Pharmacol 233:269–273CrossRefPubMedGoogle Scholar
  27. Gyires K (2005) Gastric mucosal protection: from prostaglandins to gene-therapy. Curr Med Chem 12:203–215CrossRefPubMedGoogle Scholar
  28. Halliwell B (2006) Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 141:312–322PubMedCentralCrossRefPubMedGoogle Scholar
  29. Holzer P (2000) Gastroduodenal mucosal defense. Curr Opin Gastroenterol 16:469–478CrossRefPubMedGoogle Scholar
  30. Hoppenkamps R, Thies E, Younes M, Siegers CP (1984) Glutathione and GSH-dependent enzymes in the human gastric mucosa. Klin Wochenschr 62:183–6Google Scholar
  31. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) Classification of cannabinoid receptors. XXVII international union of pharmacology. Pharmacol Rev 54:161–202CrossRefPubMedGoogle Scholar
  32. Huestis MA (2002) Cannabis (marijuana)—effects on human behavior and performance. Forensic Sci Rev 14:15PubMedGoogle Scholar
  33. Iversen L (2007) The science of marijuana. Oxford University Press, OxfordCrossRefGoogle Scholar
  34. Izzo AA, Coutts AA (2005) Cannabinoids and the digestive tract. Handb Exp Pharmacol 168:573–598CrossRefPubMedGoogle Scholar
  35. Kinsey SG, Nomura DK, O’Neal ST, Long JZ, Mahadeva A, Cravatt BF, Grider JR, Lichtman AH (2011) Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice. J Pharmacol Exp Ther 338:795–802PubMedCentralCrossRefPubMedGoogle Scholar
  36. Konturek PC, Kania J, Hahn EG, Konturek JW (2006) Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase. J Physiol Pharmacol 57:125–136PubMedGoogle Scholar
  37. Lichtenberger LM (1999) Gastroduodenal mucosal defense. Curr Opin Gastroenterol 15:463–472CrossRefPubMedGoogle Scholar
  38. Miranda KM, Espey ME, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Biol Chem 5:62–71Google Scholar
  39. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142PubMedGoogle Scholar
  40. Mózsik G, Móron F, Jávor T (1982) Cellular mechanisms of the development of gastric mucosal damage and of gastrocytoprotection induced by prostacyclin in rats. A pharmacological study. Prostaglandins Leukot Med 9:71–84CrossRefPubMedGoogle Scholar
  41. Muscara MN, Wallace JL (1999) Nitric oxide: therapeutic potential of nitric oxide donors and inhibitors. Am J Physiol 276:1313–1316Google Scholar
  42. Nalin DR, Levine MM, Rhead J, Bergquist E, Rennels M, Hughes T, O'Donnel S, Hornick RB (1978) Cannabis, hypochlorhydria, and cholera. Lancet 21(2):859–862CrossRefGoogle Scholar
  43. Pacher P, Bátkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389–462PubMedCentralCrossRefPubMedGoogle Scholar
  44. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315–424PubMedCentralCrossRefPubMedGoogle Scholar
  45. Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129–180PubMedGoogle Scholar
  46. Pertwee RG (2005) Pharmacological actions of cannabinoids. Handb Exp Pharmacol 168:1–51CrossRefPubMedGoogle Scholar
  47. Pertwee RG, Ross RA (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fat Acids 66:101–121CrossRefGoogle Scholar
  48. Rivas VJF, Garcûa R (1980) Inhibition of histamine-stimulated gastric acid secretion by ∆9–tetrahydrocannabinol in rat isolated stomach. Eur J Pharmacol 65:317–318CrossRefGoogle Scholar
  49. Sayre LM, Perry G, Smith MA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21:172–188CrossRefPubMedGoogle Scholar
  50. Shay H, Sun DCH, Gruenstein M (1954) A quantitative method for measuring spontaneous gastric secretion in the rat. Gastroenterology 26:906–913Google Scholar
  51. Shujaa N, Zadori ZS, Ronai AZ, Barna I, Mergl Z, Mozes MM, Gyires K (2009) Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat. J Physiol Pharmacol 60:93–100PubMedGoogle Scholar
  52. Sies H (1991) Oxidative stress: introduction. In: Sies H (ed) Oxidative stress: oxidants and antioxidants. Academic, LondonGoogle Scholar
  53. Sofia RD, Diamantis W, Harrison JE, Melton J (1978) Evaluation of antiulcer activity of ∆9-tetrahydrocannabinol in the Shay rat test. Pharmacology 17:173–177CrossRefPubMedGoogle Scholar
  54. Townsend DM, Tew KD, Tapiero H (2003) The importance of glutathione in human disease. Biomed Pharmacother 57:144–155CrossRefGoogle Scholar
  55. Tulassay Z, Herszényi L (2010) Gastric mucosal defense and cytoprotection. Best Pract Res Clin Gastroenterol 24:99–108CrossRefPubMedGoogle Scholar
  56. Turner JC, Mahlberg PG (1984) Separation of acid and neutral cannabinoids in Cannabis sativa L. using HPLC. In: Agurell S, Dewey WL, Willete RE (eds) Chemical, pharmacological and therapeutic agents. Academic, London, pp 79–88Google Scholar
  57. Uchiyama M, Mihara M (1978) Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271–278CrossRefPubMedGoogle Scholar
  58. Wallace JL, Miller MJ (2000) Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 119:512–520CrossRefPubMedGoogle Scholar
  59. Wallace JL, Reuter BK, Cirino G (1994) Nitric oxide-releasing non-steroidal anti-inflammatory drugs: a novel approach for reducing gastrointestinal toxicity. J Gastroenterol Hepatol 9 Suppl 1:S40–4Google Scholar
  60. Wallace JL, Flannigan KL, McKnight W, Wang L, Ferraz JG, Tuitt D (2013) Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract. J Physiol Pharmacol 64:167–75Google Scholar
  61. Warzecha Z, Dembinski A, Ceranowicz P, Dembinski M, Cieszkowski J, Kownacki P, Konturek PC (2011) Role of sensory nerves in gastroprotective effect of anandamide in rats. J Physiol Pharmacol 62:207–217PubMedGoogle Scholar
  62. Wastell C, Colin JF, MacNatighton JI, Gleeson J (1972) Selective proximal vagotomy with and without pyloroplasty. Br Med J 1:28–30PubMedCentralCrossRefPubMedGoogle Scholar
  63. Whittle BJR (1993) Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance. Br J Pharmacol 110:3–17PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2015

Authors and Affiliations

  • Omar M. E. Abdel-Salam
    • 1
    Email author
  • Rania Abdallah Ali Salama
    • 1
  • Ezz-Eddin El-Denshary
    • 2
  • Amany Ameen Sleem
    • 3
  • Marawa El-Sayed El-Shamarka
    • 1
  • Nabila Salah Hassan
    • 4
  1. 1.Department of Toxicology and NarcoticsNational Research CentreCairoEgypt
  2. 2.Department of Pharmacology and Toxicology, Faculty of PharmacyCairo UniversityGizaEgypt
  3. 3.Department of PharmacologyNational Research CentreCairoEgypt
  4. 4.Department of PathologyNational Research CentreCairoEgypt

Personalised recommendations